{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:01:56Z","timestamp":1753880516174,"version":"3.41.2"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2024,7,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n              Naphthoquine is a promising candidate for antimalarial combination therapy. Its combination with artemisinin has demonstrated excellent efficacy in clinical trials conducted across various malaria-endemic areas. A co-formulated combination of naphthoquine and azithromycin has also shown high clinical efficacy for malaria prophylaxis in Southeast Asia. Developing new combination therapies using naphthoquine will provide additional arsenal responses to the growing threat of artemisinin resistance. Furthermore, due to its long half-life, the possible interaction of naphthoquine with other drugs also needs attention. However, studies on its pharmacodynamic interactions with other drugs are still limited. In this study, the\n              <jats:italic>in vitro<\/jats:italic>\n              interactions of naphthoquine with ivermectin, atovaquone, curcumin, and ketotifen were evaluated in the asexual stage of\n              <jats:italic>Plasmodium falciparum<\/jats:italic>\n              3D7. By using the combination index analysis and the SYBR Green I-based fluorescence assay, different interaction patterns of selected drugs with naphthoquine were revealed. Curcumin showed a slight but significant synergistic interaction with naphthoquine at lower effect levels, and no antagonism was observed across the full range of effect levels for all tested ratios. Atovaquone showed a potency decline when combined with naphthoquine. For ivermectin, a significant antagonism with naphthoquine was observed at a broad range of effect levels below 75% inhibition, although no significant interaction was observed at higher effect levels. Ketotifen interacted with naphthoquine similar to ivermectin, but significant antagonism was observed for only one tested ratio. These findings should be helpful to the development of new naphthoquine-based combination therapy and the clinically reasonable application of naphthoquine-containing therapies.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>IMPORTANCE<\/jats:title>\n            <jats:p>Pharmacodynamic interaction between antimalarials is not only crucial for the development of new antimalarial combination therapies but also important for the appropriate clinical use of antimalarials. The significant synergism between curcumin and naphthoquine observed in this study suggests the potential value for further development of new antimalarial combination therapy. The finding of a decline in atovaquone potency in the presence of naphthoquine alerts to a possible risk of treatment or prophylaxis failure for atovaquone\u2013proguanil following naphthoquine-containing therapies. The observation of antagonism between naphthoquine and ivermectin raised a need for concern about the applicability of naphthoquine-containing therapy in malaria-endemic areas with ivermectin mass drug administration deployed. Considering the role of atovaquone\u2013proguanil as a major alternative when first-line artemisinin-based combination therapy is ineffective and the wide implementation of ivermectin mass drug administration in malaria-endemic countries, the above findings will be important for the appropriate clinical application of antimalarials involving naphthoquine-containing therapies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/spectrum.00630-24","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:00:51Z","timestamp":1716469251000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["<i>In vitro<\/i>\n            interaction of naphthoquine with ivermectin, atovaquone, curcumin, and ketotifen in the asexual blood stage of\n            <i>Plasmodium falciparum<\/i>\n            3D7"],"prefix":"10.1128","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6220-3065","authenticated-orcid":true,"given":"Ruotong","family":"Liu","sequence":"first","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China"},{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoming","family":"Li","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China"},{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China"},{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baogang","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongna","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhe","family":"Liao","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China"},{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2146-7342","authenticated-orcid":false,"given":"Qin","family":"Xu","sequence":"additional","affiliation":[{"name":"Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5089-989X","authenticated-orcid":true,"given":"Zhu-Chun","family":"Bei","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6265-7079","authenticated-orcid":false,"given":"Yabin","family":"Song","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","volume-title":"World malaria report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. 2023. World malaria report 2023. World Health Organization, Geneva."},{"key":"e_1_3_4_3_2","volume-title":"Report on antimalarial drug efficacy resistance and response: 10 years of surveillance (2010-2019)","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Report on antimalarial drug efficacy resistance and response: 10 years of surveillance (2010-2019). World Health Organization, Geneva."},{"key":"e_1_3_4_4_2","volume-title":"World malaria report 2022","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. 2022. World malaria report 2022. World Health Organization, Geneva."},{"key":"e_1_3_4_5_2","volume-title":"Global technical strategy for malaria 2016\u20132030","author":"World Health Organization 2021","year":"2021","unstructured":"World Health Organization 2021. 2021. Global technical strategy for malaria 2016\u20132030. World Health Organization, Geneva."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2020.09.011"},{"key":"e_1_3_4_7_2","first-page":"77","article-title":"Studies on antimalarials synthesis of 4-arylamino-tert-butylaminomethyl phenols (author\u2019s transl)","volume":"17","author":"Li FL","year":"1982","unstructured":"Li FL, Wang LH, Ding DB, Yang JD, Gao XS. 1982. Studies on antimalarials synthesis of 4-arylamino-tert-butylaminomethyl phenols (author\u2019s transl). Yao Xue Xue Bao 17:77\u201379.","journal-title":"Yao Xue Xue Bao"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2003.11.008"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06250-11"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0919-5"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011547"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0572-5"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2016.1192462"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02307-19"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00793-18"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1018"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01730-22"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00498"},{"key":"e_1_3_4_19_2","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. 2015. Guidelines for the treatment of malaria. 3rd edition. World Health Organization, Geneva.","edition":"3"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9135617"},{"key":"e_1_3_4_21_2","first-page":"18","article-title":"The role of curcumin as an antimalarial agent","volume":"11","author":"Ekawardhani S","year":"2020","unstructured":"Ekawardhani S, Berbudi A. 2020. The role of curcumin as an antimalarial agent. Sys Rev Pharm 11:18\u201325.","journal-title":"Sys Rev Pharm"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2015.06.035"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00920-12"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01948-15"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2017.03.002"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.324319"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057302"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S62756"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2002.2241"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00177-06"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01238-06"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.11.008"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00562"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2394"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.2174\/0118715265276270240222070244"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00085-19"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02005-16"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00741-20"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30633-4"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00557-0"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.781840"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-271-6:477"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01607-06"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.10"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(84)90007-4"},{"key":"e_1_3_4_46_2","unstructured":"R Core Team. 2023. R: a language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria. Available from: https:\/\/www.R-project.org\/"},{"key":"e_1_3_4_47_2","unstructured":"Posit team.2023. Rstudio: integrated development environment for R. Posit Software PBC Boston MA. Available from: http:\/\/www.posit.co\/"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1201\/b21966"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00630-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00630-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:03:42Z","timestamp":1719925422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00630-24"}},"subtitle":[],"editor":[{"given":"Denis","family":"Sereno","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,2]]}},"alternative-id":["10.1128\/spectrum.00630-24"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00630-24","relation":{},"ISSN":["2165-0497"],"issn-type":[{"type":"electronic","value":"2165-0497"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"2024-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00630-24"}}